Small victories add up to paradigm shifts for hard-to-treat tumorsDecember 17, 2014GastroenterologyGynecologic CancerMelanoma
A rare case of ovarian carcinosarcoma with neuroendocrine differentiationFebruary 20, 2014Gynecologic Cancer
Synthetic lethality: beating cancer at its own gameFebruary 4, 2014Breast CancerGynecologic CancerLung Cancer
Multimodality therapy for uterine serous carcinoma and the association with overall and relapse-free survivalDecember 12, 2013Gynecologic Cancer
Illness perceptions matter: understanding quality of life and advanced illness behaviors in female patients with late-stage cancerDecember 1, 2013Patient & Survivor CareBreast CancerGynecologic CancerLung Cancer
Benign metastasizing leiomyoma: ‘a sheep in wolf’s clothing’May 29, 2013Gynecologic CancerRare Diseases
BRCA1/2 testing and cancer risk management in underserved women at a public hospitalDecember 1, 2012Gynecologic CancerBreast Cancer
Spiritual Well-Being and Quality of Life of Women with Ovarian Cancer and Their Spouses March 22, 2012Patient & Survivor CareGynecologic Cancer
Commentary: Depression Stymies Care in Latina Breast Cancer SurvivorsSeptember 19, 2011Breast CancerGynecologic CancerPatient & Survivor Care
Symptom Experience in Patients with Gynecological Cancers: The Development of Symptom Clusters through Patient NarrativesApril 2, 2011Gynecologic Cancer
Pilot Study of the Prospective Identification of Changes in Cognitive Function During Chemotherapy Treatment for Advanced Ovarian Cancer January 25, 2011Gynecologic CancerPatient & Survivor Care
Farletuzumab (MORAb-003) in platinum-sensitive ovarian cancer patients experiencing a first relapseApril 1, 2010Gynecologic Cancer
